Annual Total Long Term Liabilities
$45.68 M
+$39.60 M+650.61%
31 December 2023
Summary:
Inozyme Pharma annual total long term liabilities is currently $45.68 million, with the most recent change of +$39.60 million (+650.61%) on 31 December 2023. During the last 3 years, it has risen by +$44.40 million (+3449.49%). INZY annual total long term liabilities is now -41.38% below its all-time high of $77.93 million, reached on 31 December 2019.INZY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$42.23 M
-$3.52 M-7.70%
30 September 2024
Summary:
Inozyme Pharma quarterly total long term liabilities is currently $42.23 million, with the most recent change of -$3.52 million (-7.70%) on 30 September 2024. Over the past year, it has increased by +$9.02 million (+27.14%). INZY quarterly long term liabilities is now -62.23% below its all-time high of $111.80 million, reached on 30 June 2020.INZY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +650.6% | +27.1% |
| 3 y3 years | +3449.5% | +1392.7% |
| 5 y5 years | -17.0% | - |
INZY Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +3449.5% | -7.7% | +1785.2% |
| 5 y | 5 years | -41.4% | +3449.5% | -62.2% | |
| alltime | all time | -41.4% | +3449.5% | -62.2% |
Inozyme Pharma Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $42.23 M(-7.7%) |
| June 2024 | - | $45.75 M(+0.1%) |
| Mar 2024 | - | $45.70 M(+0.0%) |
| Dec 2023 | $45.68 M(+650.6%) | $45.68 M(+37.5%) |
| Sept 2023 | - | $33.21 M(-0.1%) |
| June 2023 | - | $33.26 M(+28.6%) |
| Mar 2023 | - | $25.87 M(+325.0%) |
| Dec 2022 | $6.09 M | $6.09 M(-0.4%) |
| Sept 2022 | - | $6.11 M(+172.7%) |
| June 2022 | - | $2.24 M(-8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $2.44 M(-7.5%) |
| Dec 2021 | $2.64 M(+105.1%) | $2.64 M(-6.7%) |
| Sept 2021 | - | $2.83 M(-6.1%) |
| June 2021 | - | $3.01 M(-5.7%) |
| Mar 2021 | - | $3.19 M(+148.2%) |
| Dec 2020 | $1.29 M(-98.3%) | $1.29 M(+1.9%) |
| Sept 2020 | - | $1.26 M(-98.9%) |
| June 2020 | - | $111.80 M(>+9900.0%) |
| Mar 2020 | - | $0.00(-100.0%) |
| Dec 2019 | $77.93 M(+41.6%) | $77.93 M |
| Dec 2018 | $55.03 M | - |
FAQ
- What is Inozyme Pharma annual total long term liabilities?
- What is the all time high annual total long term liabilities for Inozyme Pharma?
- What is Inozyme Pharma annual total long term liabilities year-on-year change?
- What is Inozyme Pharma quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Inozyme Pharma?
- What is Inozyme Pharma quarterly long term liabilities year-on-year change?
What is Inozyme Pharma annual total long term liabilities?
The current annual total long term liabilities of INZY is $45.68 M
What is the all time high annual total long term liabilities for Inozyme Pharma?
Inozyme Pharma all-time high annual total long term liabilities is $77.93 M
What is Inozyme Pharma annual total long term liabilities year-on-year change?
Over the past year, INZY annual total long term liabilities has changed by +$39.60 M (+650.61%)
What is Inozyme Pharma quarterly total long term liabilities?
The current quarterly long term liabilities of INZY is $42.23 M
What is the all time high quarterly long term liabilities for Inozyme Pharma?
Inozyme Pharma all-time high quarterly total long term liabilities is $111.80 M
What is Inozyme Pharma quarterly long term liabilities year-on-year change?
Over the past year, INZY quarterly total long term liabilities has changed by +$9.02 M (+27.14%)